These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31221862)

  • 1. Prodromes and Preclinical Detection of Brain Diseases: Surveying the Ethical Landscape of Predicting Brain Health.
    Ahlgrim NS; Garza K; Hoffman C; Rommelfanger KS
    eNeuro; 2019; 6(4):. PubMed ID: 31221862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical issues in the neurology of aging and cognitive decline.
    Klein E; Karlawish J
    Handb Clin Neurol; 2013; 118():233-42. PubMed ID: 24182382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond V40.31: Narrative Phenomenology of Wandering in Autism and Dementia.
    Solomon O; Lawlor MC
    Cult Med Psychiatry; 2018 Jun; 42(2):206-243. PubMed ID: 29368117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for preclinical Alzheimer's disease.
    Tan CC; Yu JT; Tan L
    J Alzheimers Dis; 2014; 42(4):1051-69. PubMed ID: 25024325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early detection of autism spectrum disorders: emerging symptoms and biomarkers].
    Goussé V; Amsellem F; Delorme R
    Bull Acad Natl Med; 2016 Mar; 200(3):415-22. PubMed ID: 28627160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Science disconnected: the translational gap between basic science, clinical trials, and patient care in Alzheimer's disease.
    Gregory S; Saunders S; Ritchie CW
    Lancet Healthy Longev; 2022 Nov; 3(11):e797-e803. PubMed ID: 36356629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subjective Cognitive Decline in Preclinical Alzheimer's Disease.
    Rabin LA; Smart CM; Amariglio RE
    Annu Rev Clin Psychol; 2017 May; 13():369-396. PubMed ID: 28482688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ADI-R and ADOS and the differential diagnosis of autism spectrum disorders: Interests, limits and openings].
    Frigaux A; Evrard R; Lighezzolo-Alnot J
    Encephale; 2019 Nov; 45(5):441-448. PubMed ID: 31495549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging or imagining? A neuroethics challenge informed by genetics.
    Illes J; Racine E
    Am J Bioeth; 2005; 5(2):5-18. PubMed ID: 16036688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis.
    Parnetti L; Chipi E; Salvadori N; D'Andrea K; Eusebi P
    Alzheimers Res Ther; 2019 Jan; 11(1):7. PubMed ID: 30646955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What happens in the brain of my patients? Neuroimaging and neurogenetics as ethical challenges in medicine].
    Synofzik M
    Dtsch Med Wochenschr; 2007 Dec; 132(49):2646-9. PubMed ID: 18050032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical Approach to Prevention of Schizophrenia - Concepts and Challenges.
    Radic K; Curkovic M; Bagaric D; Vilibic M; Tomic A; Zivkovic M
    Psychiatr Danub; 2018 Mar; 30(1):35-40. PubMed ID: 29546856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminating autism spectrum disorders from schizophrenia by investigation of mental state attribution on an on-line mentalizing task: A review and meta-analysis.
    Bliksted V; Ubukata S; Koelkebeck K
    Schizophr Res; 2016 Mar; 171(1-3):16-26. PubMed ID: 26817402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing prodromal stage of bipolar disorder and early onset schizophrenia spectrum disorders during adolescence.
    Kafali HY; Bildik T; Bora E; Yuncu Z; Erermis HS
    Psychiatry Res; 2019 May; 275():315-325. PubMed ID: 30953877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project.
    Ritchie K; Ropacki M; Albala B; Harrison J; Kaye J; Kramer J; Randolph C; Ritchie CW
    Alzheimers Dement; 2017 Feb; 13(2):186-195. PubMed ID: 27702619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-based interventions for neurologic conditions: ethical challenges for early human trials.
    Mathews DJ; Sugarman J; Bok H; Blass DM; Coyle JT; Duggan P; Finkel J; Greely HT; Hillis A; Hoke A; Johnson R; Johnston M; Kahn J; Kerr D; Kurtzberg J; Liao SM; McDonald JW; McKhann G; Nelson KB; Rao M; Regenberg A; Siegel AW; Smith K; Solter D; Song H; Vescovi A; Young W; Gearhart JD; Faden R
    Neurology; 2008 Jul; 71(4):288-93. PubMed ID: 18463365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAP--advancing the evaluation of preclinical Alzheimer disease treatments.
    Reiman EM; Langbaum JB; Tariot PN; Lopera F; Bateman RJ; Morris JC; Sperling RA; Aisen PS; Roses AD; Welsh-Bohmer KA; Carrillo MC; Weninger S
    Nat Rev Neurol; 2016 Jan; 12(1):56-61. PubMed ID: 26416539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
    Dubois B; Hampel H; Feldman HH; Scheltens P; Aisen P; Andrieu S; Bakardjian H; Benali H; Bertram L; Blennow K; Broich K; Cavedo E; Crutch S; Dartigues JF; Duyckaerts C; Epelbaum S; Frisoni GB; Gauthier S; Genthon R; Gouw AA; Habert MO; Holtzman DM; Kivipelto M; Lista S; Molinuevo JL; O'Bryant SE; Rabinovici GD; Rowe C; Salloway S; Schneider LS; Sperling R; Teichmann M; Carrillo MC; Cummings J; Jack CR;
    Alzheimers Dement; 2016 Mar; 12(3):292-323. PubMed ID: 27012484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Alzheimer's Disease: Implications for Refinement of the Concept.
    Vos SJB; Visser PJ
    J Alzheimers Dis; 2018; 64(s1):S213-S227. PubMed ID: 29865060
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.